Curaleaf issues statement on reported interest in Cronos
Curaleaf Holdings Inc. responded late Friday to reports it was among those interested in buying Canadian cannabis company Cronos Inc. (CRON.T). Curaleaf said the Canadian Investment Regulatory Organization had requested a comment on market speculation. "As previously disclosed, the company regularly examines transactions including partnerships, possible acquisitions, sales and mergers with third parties," the company said in a statement. "There is no guarantee that any potential transaction will materialize." Earlier Friday, Curaleaf said it did not comment on market speculation about reports of a transaction unless required by law Shares of Curaleaf closed Friday up nearly 16%, while Cronos shares finished up nearly 7%.
-Wallace Witkowski
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-07-23 1655ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations